Ability of higenamine and related compounds to enhance glucose uptake in L6 cells. Issue 24 (15th December 2017)

• Record Type: Journal Article
• Authors: Kato, Eisuke; Kimura, Shunsuke; Kawabata, Jun
• Is Part Of: Bioorganic & medicinal chemistry. Volume 25:Issue 24(2017)
• Page Start: 6412
• Page End: 6416
• Publication Date: 2017-12-15
• Subjects: β2-Adrenergic receptor -- Tetrahydroisoquinoline -- Glucose uptake -- Muscle cell -- Diabetes; Bioorganic chemistry -- Periodicals; Pharmaceutical chemistry -- Periodicals; Biochemistry -- Periodicals; Chemistry, Clinical -- Periodicals; Chemistry, Organic -- Periodicals; Chimie bio-organique -- Périodiques; Chimie pharmaceutique -- Périodiques; 615.19
• DOI: 10.1016/j.bmc.2017.10.011
• Languages: English
• ISSNs: 0968-0896

Abstract

Graphical abstract: Abstract: β2-Adrenergic receptor (β2AR) agonists are employed as bronchodilators to treat pulmonary disorders, but are attracting attention for their modulation of glucose handling and energy expenditure. Higenamine is a tetrahydroisoquinoline present in several plant species and has β2AR agonist activity, but the involvement of each functional groups in β2AR agonist activity and its effectiveness compared with endogenous catecholamines (dopamine, epinephrine, and norepinephrine) has rarely been studied. Glucose uptake of muscle cells are known to be induced through β2AR activation. Here, the ability to enhance glucose uptake of higenamine was compared with that of several methylated derivatives of higenamine or endogenous catecholamines. We found that: (i) the functional groups of higenamine except for the 4′-hydroxy group are required to enhance glucose uptake; (ii) higenamine shows a comparable ability to enhance glucose uptake with that of epinephrine and norepinephrine; (iii) the S -isomer shows a greater ability to enhance glucose uptake compared with that of the R -isomer.